Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vivani Medical Inc VANI

Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:VANI)

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Business Wire November 13, 2024

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Business Wire October 22, 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Business Wire September 26, 2024

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Business Wire September 23, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Business Wire September 4, 2024

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire August 28, 2024

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Business Wire August 13, 2024

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Business Wire July 11, 2024

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Business Wire June 13, 2024

Opinion & Analysis (NDAQ:VANI)

No current opinion is available.

Bullboard Posts (NDAQ:VANI)

Vivani Medical, Inc. (NASDAQ:VANI): Innovative Miniature Imp

http://beyondspx.com/2024/08/03/vivani-medical-inc-nasdaqvani-innovative-miniature-implants-poised-to-transform-chronic-disease...
MikeTester - August 3, 2024

Chat with Dr. Robert Greenberg, former CEO of Second Sight

Dr. Robert Greenberg, current Chairman and CEO of Alfred Mann Foundation and former CEO of Second Sight Medical Products...
LocomotiveB - June 8, 2021

EYES...big runner this a.m

Now in PB mode ......has to hold $6.12 or she be head south to 2nd target of $5.74  Cheers !
Iseneschal - May 12, 2021

RE:ACDC

https://m.youtube.com/watch?v=SsA2yXyh7gs&t=306s
Kruithof - March 15, 2021

ACDC

https://ca.finance.yahoo.com/news/minto-apartment-reit-reports-third-220000314.html
Kruithof - March 13, 2021

RE:RE:ACDC

https://www.streetwisereports.com/article/2021/03/09/the-future-of-battery-storage-and-management.html?fbclid...
Kruithof - March 10, 2021